...
首页> 外文期刊>The Journal of investigative dermatology. >Basal-cell adhesion molecule (B-CAM) is induced in epithelial skin tumors and inflammatory epidermis, and is expressed at cell-cell and cell-substrate contact sites.
【24h】

Basal-cell adhesion molecule (B-CAM) is induced in epithelial skin tumors and inflammatory epidermis, and is expressed at cell-cell and cell-substrate contact sites.

机译:基底细胞粘附分子(B-CAM)在上皮性皮肤肿瘤和炎性表皮中被诱导,并在细胞与细胞和细胞与基质的接触部位表达。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Basal-cell adhesion molecule (B-CAM) is a 90 kDa cell surface glycoprotein of the immunoglobulin superfamily that functions as a laminin-binding receptor. B-CAM is upregulated following malignant transformation of some cell types in vivo and in vitro, thus being a candidate molecule involved in tumor progression. As cutaneous distribution and function of B-CAM are largely unknown, we have studied its expression and regulation in normal and diseased human skin. In normal skin, B-CAM was expressed by endothelial cells of dermal blood vessels. In contrast, B-CAM was strongly upregulated within the tumor tissue of both malignant and benign epithelial skin tumors, including basal cell carcinomas, squamous cell carcinomas, keratoacanthomas, and common warts. Transformation-associated upregulation was confirmed in vitro, but normal keratinocytes also expressed B-CAM under culture conditions. Interestingly, the basal epidermal layer of normal-appearing skin surrounding the tumors also expressed B-CAM, and B-CAM were induced on the basal and apicolateral surfaces of basal keratinocytes in inflammatory skin disorders suggesting transformation-independent mechanisms of epidermal induction of the B-CAM. Immunoelectron microscopy studies of cultured transformed keratinocytes revealed that B-CAM was expressed at cell-cell and cell-substrate contact sites. Halting proliferation of transformed keratinocytes through cytostatic drugs resulted in decreased B-CAM synthesis. Likewise, inducing terminal differentiation in keratinocyte cultures by increasing the Ca(2+) concentration in the medium decreased B-CAM expression. In contrast, both ultraviolet A and B irradiation of cultured human keratinocytes resulted in significantly increased expression of the B-CAM. Overall, it appears that B-CAM expression in human skin is associated with activated states of keratinocytes, and that B-CAM may be involved in cell-cell adhesion or migration, in addition to its known function as a laminin receptor. J Invest Dermatol 115:1047-1053 2000
机译:基底细胞粘附分子(B-CAM)是免疫球蛋白超家族的一种90 kDa细胞表面糖蛋白,起层粘连蛋白结合受体的作用。在体内和体外某些细胞类型发生恶性转化后,B-CAM被上调,因此是参与肿瘤进展的候选分子。由于B-CAM的皮肤分布和功能在很大程度上尚不清楚,因此我们研究了其在正常和患病皮肤中的表达和调控。在正常皮肤中,B-CAM由真皮血管的内皮细胞表达。相反,B-CAM在恶性和良性上皮性皮肤肿瘤的肿瘤组织中都强烈上调,包括基底细胞癌,鳞状细胞癌,角膜棘皮瘤和普通疣。在体外证实了与转化相关的上调,但是正常的角质形成细胞在培养条件下也表达B-CAM。有趣的是,肿瘤周围正常出现的皮肤的基底表皮层也表达了B-CAM,并且在炎症性皮肤病中基底角质形成细胞的基底和顶侧表面诱导了B-CAM,提示表皮诱导B的转化独立机制-CAM。培养的转化的角质形成细胞的免疫电子显微镜研究表明,B-CAM在细胞-细胞和细胞-基质接触部位表达。通过细胞抑制药物阻止转化的角质形成细胞的增殖导致B-CAM合成减少。同样,通过增加培养基中Ca(2+)的浓度来诱导角质形成细胞培养的终末分化,从而降低B-CAM的表达。相比之下,培养的人角质形成细胞的紫外线A和B照射均导致B-CAM的表达显着增加。总体而言,似乎人皮肤中的B-CAM表达与角质形成细胞的活化状态有关,并且B-CAM除了具有已知的层粘连蛋白受体功能外,还可能参与细胞与细胞的粘附或迁移。 J投资皮肤病杂志115:1047-1053 2000

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号